Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Ixabepilone vs Control in Advanced Endometrial Cancer
NCT00883116Phase 3Terminated
- Sponsor
- R-Pharm
- Start
- Aug 2009
- Primary completion
- Jun 2012
- Modality
- Small Molecules
- Countries
- 19
01
Overview
A Phase 3 trial of ixabepilone in endometrial cancer (EC), sponsored by R-Pharm. Started Aug 2009; status: terminated.
02
Drugs
ixabepilone
03
Conditions
endometrial cancer (EC)
Beyond the preview
Go deeper on NCT00883116.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00883116.